DUBLIN--(BUSINESS WIRE)--The "North America Coated Endotracheal Tube Market Analysis (2017-2023)" report has been added to ResearchAndMarkets.com's offering.
The North America Coated Endotracheal Tube Market is expected to witness market growth of 5.9% CAGR during the forecast period (2017 - 2023).
Endotracheal tube is a metal or plastic tube that is introduced in the trachea via the mouth or nose to validate the adequate exchange of oxygen and carbon dioxide and at the same time maintain the patient's airway. Coated endotracheal tube is a specific tube coated with antithrombotic agents that is used to prevent coagulation or antibiotic agents such as polyvinyl chloride, silver, and various drugs to limit the growth of the bacteria on the surface of endotracheal tube.
Growing number of surgical procedures due to increasing chronic respiratory diseases such as cardiovascular diseases, respiratory diseases, diabetes, cancer, and other lung injuries are the factors that contribute to the growth of the market. Moreover, growing need for ventilator associated pneumonia and growth in geriatric population, that is highly prone to chronic diseases also significantly contribute to the market growth. However, post-operative complications related to endotracheal intubation and lack of skilled professionals are the factors that limit the market growth.
Key Topics Covered:
1. Market Scope & Methodology
2. Market Overview
3. North America Coated Endotracheal Tube Market
4. North America Coated Endotracheal Tube Market by Intubation
5. North America Coated Endotracheal Tube Market by Application
6. North America Coated Endotracheal Tube Market by Country
7. Company Profiles
- Teleflex Inc.
- C.R. Bard, Inc.
- Venner Medical International
- Sonoma Pharmaceuticals Inc.
- Hospiteknik Healthcare
- N8 Medical, LLC.
- Medline Industries, Inc.
- Enox Biopharma, Inc.
- Bactiguard Holding AB
- Armstrong Medical
For more information about this report visit https://www.researchandmarkets.com/research/8tcdrx/north_america?w=4